Hikma Pharmaceuticals
Presence
Hikma Pharmaceuticals is one of the...
Hikma Pharmaceuticals is a company listed under the stock ticker HIK (GB).
Hikma Pharmaceuticals has a direct presence in 2 countries.
They are in:
- Pharmaceuticals67%
- Fund33%
Acquisition, funding and merger involving Hikma Pharmaceuticals.
- Hikma Pharmaceuticals has acquired Custopharm (posted on April 22 2022).
Executives
View the org chart displaying its 40 main executives
Most searched biographies at Hikma Pharmaceuticals
- Riad Mishlawi, Chief Executive Officer
- Said Darwazah, Executive Chairman of the Board
- Cynthia Flowers, Independent Non-Executive Director
Popular executive movements at Hikma Pharmaceuticals
- Brian Hoffmann, President, Generics Division, will leave the company on May 1, 2024 (posted on April 17 2024).
- Hafrun Fridriksdottir will join the company as President of Generics on May 1, 2024 (posted on April 17 2024).
- Helen Middlemist who is Deputy Company Secretary, will be promoted to Company Secretary on Jan. 1, 2024 (posted on December 29 2023).
Click here to view some more movements at Hikma Pharmaceuticals
Create your alert
to follow the executive moves at Hikma Pharmaceuticals.
Pharmaceuticals
Hikma Pharmaceuticals has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Hikma Pharmaceuticals
- Hikma’s Executive Vice Chairman and President of MENA Joins Rakuten Medical’s Board of Directors
- Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facility
- Hikma delivers strong 2023 performance and a positive outlook for 2024
- Hikma launches Alvimopan Capsules in the US
- Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic® into the Saudi, Jordanian and Iraqi Markets
- Hikma appoints Julie Hill, as Senior Vice President, Corporate Quality Compliance/Health and Safety
- Hikma Announces Agreement in Principle for Nationwide US Opioid Settlement Framework
- Hikma announces US launch of COMBOGESIC® IV
- Notice of preliminary results
- Activ Surgical, a Hikma Ventures portfolio company, completes the first international procedure using ActivSight™ Intelligent Light at Abdali Hospital in Jordan
- View more press releases Close
Social media about Hikma Pharmaceuticals
- Hikma Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Hikma Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Riad Mishlawi 
Call Hikma Pharmaceuticals at +44 207...
